Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment

Int J Antimicrob Agents. 2021 Mar;57(3):106292. doi: 10.1016/j.ijantimicag.2021.106292.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • Azithromycin / therapeutic use*
  • COVID-19 Drug Treatment*
  • Drug Therapy, Combination
  • Humans
  • Hydroxychloroquine / therapeutic use*
  • SARS-CoV-2 / drug effects*

Substances

  • Antiviral Agents
  • Hydroxychloroquine
  • Azithromycin